Compare Moderna, Inc. (MRNA) vs Toronto-Dominion Bank (TD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs Toronto-Dominion Bank — how do they compare? Moderna, Inc. trades at $60.53 (market cap $24.18B), while Toronto-Dominion Bank trades at $121.35 (market cap $200.48B). The key difference: Toronto-Dominion Bank is far larger — about 8.3× Moderna, Inc.'s market cap, and Toronto-Dominion Bank pays a 2.63% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| MRNA | TD | |
|---|---|---|
Market Cap | $24.18B | $200.48B |
Sector | Health | Financials |
52-Week High | $81.80 | $124.80 |
52-Week Low | $22.36 | $72.85 |
Enterprise Value | $20.33B | — |
Dividend Yield | — | 2.63% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About Toronto-Dominion Bank
Toronto-Dominion is one of Canada's two largest banks and operates three business segments: Canadian retail banking, U.S. retail banking, and wholesale banking. The bank's U.S. operations span from Maine to Florida, with a strong presence in the Northeast. It also has a 13% ownership stake in Charles Schwab.
Read more on TD →
